Scientists test gene therapy approach for rare immune diseases in lab
NCT ID NCT07261891
Summary
This study aims to understand how JAK inhibitor drugs affect immune cells in people with rare genetic immune disorders. Researchers will examine blood samples from 20 adult participants to see how these drugs change cell behavior and test whether a gene therapy approach might work in the lab. This is early-stage research to gather information, not a treatment trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY IMMUNODEFICIENCY DISEASES (PID) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospitals Leuven,
RECRUITINGLeuven, Vlaams-Brabant, 3000, Belgium
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.